.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Colorcon
Citi
Fish and Richardson
Queensland Health
Merck
Healthtrust
Moodys
Express Scripts

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018709

« Back to Dashboard

NDA 018709 describes CAPOZIDE 50/25, which is a drug marketed by Apothecon and is included in one NDA. Additional details are available on the CAPOZIDE 50/25 profile page.

The generic ingredient in CAPOZIDE 50/25 is captopril; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.

Summary for 018709

Tradename:4
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Oct 12, 1984TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Oct 12, 1984TE:RLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Oct 12, 1984TE:RLD:Yes

Expired Orange Book Patents for NDA: 018709

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
ApotheconCAPOZIDE 50/25captopril; hydrochlorothiazideTABLET;ORAL018709-003Oct 12, 1984► Subscribe► Subscribe
ApotheconCAPOZIDE 25/15captopril; hydrochlorothiazideTABLET;ORAL018709-001Oct 12, 1984► Subscribe► Subscribe
ApotheconCAPOZIDE 50/25captopril; hydrochlorothiazideTABLET;ORAL018709-003Oct 12, 1984► Subscribe► Subscribe
ApotheconCAPOZIDE 50/15captopril; hydrochlorothiazideTABLET;ORAL018709-004Oct 12, 1984► Subscribe► Subscribe
ApotheconCAPOZIDE 25/25captopril; hydrochlorothiazideTABLET;ORAL018709-002Oct 12, 1984► Subscribe► Subscribe
ApotheconCAPOZIDE 50/15captopril; hydrochlorothiazideTABLET;ORAL018709-004Oct 12, 1984► Subscribe► Subscribe
ApotheconCAPOZIDE 25/25captopril; hydrochlorothiazideTABLET;ORAL018709-002Oct 12, 1984► Subscribe► Subscribe
ApotheconCAPOZIDE 25/15captopril; hydrochlorothiazideTABLET;ORAL018709-001Oct 12, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Healthtrust
Citi
Farmers Insurance
Cerilliant
Daiichi Sankyo
QuintilesIMS
Cantor Fitzgerald
Covington
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot